News
$5Bn Pharmaceutical Cooperation For Bispecific Antibodies
Ivonescimab (PD-1/VEGF, AK112), a ground-breaking bispecific antibody, will be out-licensed by Biopharma Akeso Inc. to Summit Therapeutics Inc. for use in research and development and commercialization in the US, Canada, Europe, and Japan. This agreement might be worth up...
News
Curing Cholestatic Liver Disease After Cognitive Impairment
Cholestatic Bile flow can be hampered by liver conditions like primary biliary cholangitis (PBC), which can result in neurological problems.
There is presently no known cure for the ailment, and the causes of the onset of such neurological symptoms are...
News
3D COF Shows Good Hydrogen, CO2, And Methane Adsorption
In order to provide effective, extended-release medication delivery, Japanese researchers have developed TUS-84, a new three-dimensional (3D) covalent organic framework (COF) having a scu-c topology for the first time. The research was published in Applied Materials & Interfaces by...
Industry Reports
Top Biopharma Companies Show A Dip In Market Cap For Q3
The market capitalization of the top 20 biopharmaceutical businesses worldwide has decreased by 9.1%, from $3.45 trillion in Q2 2022 to $3.14 trillion in Q3 2022, as a result of growing generic competition and a decline in demand for...
Drug Research
EMA Advocates For Recall of Pholcodine Drugs From EU Market
PRAC, EMA's safety committee, has completed its review of pholcodine-containing medications used to treat nonproductive (dry) cough in adults and children as well as cold and flu symptoms when combined with other active ingredients. PRAC has recommended that the...
Drug Research
Regulations And Directive Revisions For Human Medicines
What changes are in store for the European Human Medicines Directive and Regulation when it is amended at the end of 2022?
The current European Union (EU) regulatory framework was created in 1995, and the European Medicines Agency (EMA) now...
Drug Research
Vaccines Europe Undertakes Its First Regulatory Evaluation
With 100 vaccine candidates as of July 2022, Vaccines Europe has released its first pipeline evaluation of the 15 firms that make up its membership.
The analysis uncovered a pipeline that uses a variety of new technology platforms to address...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read